Myeloperoxidase – A Key Target Involved in the Progression of HFpEF

Time: 9:00 am
day: Day One


  • Learn how disease drivers in HFpEF are different to HFrEF
  • Understand how MPO is linked to HFpEF severity, and involved in fibrosis, inflammation, and microvascular dysfunction
  • Explore how inhibiting MPO has beneficial effects in patients with HFpEF